|
PLENARY SPEAKERS
Eric Carreira, Professor, ETH, Zurich, Switzerland
"Our Recent Progress in Total Synthesis"
Janine Cossy, EPSCI, Paris, France
"Natural Products, a Source of Inspiration for Methodologies"
Frank Fang, Senior Executive Director, Eisai Research Institute, Andover, MA, USA
"Total Synthesis of Natural Product Drug Candidates"
Ben Feringa, Professor, University of Groningen, The Netherlands
"Progress in Chemistry of Materials"
Joel Hawkins, Senior Research Fellow, Pfizer, NY, USA
"New Chemistries and Technologies for Pharmaceutical Process R&D"
Amir Hoveyda, Boston College, MA, USA
"New Catalyst and Method Discovery Driven by Natural Product Synthesis"
Philip Kocienski, University of Leeds, UK
"A Synthesis of Ionomycin"
Stephen Martin, University of Texas, Austin, TX, USA
"Selected Vignettes from Synthesis of Heterocyclic Natural Products"
Mike Martinelli, Senior Director, Arena Pharmaceuticals, San Diego, CA, USA
"Development of Chemical Processes Towards Chiral Heterocycles"
Koji Nakanishi, Columbia University, NY, USA
"Some Heterocyclic Natural Products"
Chris Senanayake, Vice President, Chemical Development, Boehringer Ingelheim, Germany
"Practical Synthetic Methodologies for Heterocyclic Drug Development"
Barry Sharpless, Scripps Research Institute, La Jolla, CA, USA
"New Uses for High Energy Nitrogen Compounds"
|